Charles River Laboratories International (CRL) Current Assets (2009 - 2025)

Charles River Laboratories International's Current Assets history runs 17 years deep, the most recent figure standing at $1.4 billion for Q4 2025.

• In Q4 2025, Current Assets rose 3.13% year-over-year to $1.4 billion; the TTM figure through Dec 2025 stood at $1.4 billion (up 3.13% YoY), while the FY2025 annual figure was $1.4 billion, up 3.13% from the prior year.
• Current Assets was $1.4 billion for Q4 2025 at Charles River Laboratories International, down from $1.5 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.7 billion in Q1 2024 to a low of $1.3 billion in Q2 2021.
• Historically, Current Assets has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
• The sharpest annual moves came in 2021 and 2024: Current Assets rose 17.79% in 2021, then retreated 12.78% in 2024.
• A 5-year view of Current Assets shows it stood at $1.3 billion in 2021, then rose by 12.95% to $1.4 billion in 2022, then advanced by 11.79% to $1.6 billion in 2023, then retreated by 12.78% to $1.4 billion in 2024, then climbed by 3.13% to $1.4 billion in 2025.
• The last three Current Assets figures came in at $1.4 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025), per Business Quant data.